Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

2810433K01Rik Activators

2810433K01Rik Activators are a carefully selected group of chemical compoundsthat leverage various signaling pathways to indirectly enhance the functional activity of 2810433K01Rik. Forskolin serves as a key activator in this repertoire through its ability to stimulate adenylate cyclase, leading to an increase in cAMP levels and subsequent activation of PKA. This cascade effect may result in the phosphorylation of substrates related to 2810433K01Rik, thereby amplifying its activity. In a similar vein, Isoproterenol leverages adrenergic signals to boost cAMP production, which could be beneficial for 2810433K01Rik activation if it's part of adrenergic signaling pathways. Genistein, by inhibiting tyrosine kinases, potentially eases the regulatory constraints on 2810433K01Rik, while EGCG's broad kinase inhibition might remove inhibitory phosphorylations on pathways involving 2810433K01Rik. Furthermore, the manipulation of intracellular calcium levels by compounds such as Ionomycin, Thapsigargin, and A23187, suggests a strategy to activate calcium-dependent kinases that could target 2810433K01Rik or its associated pathways.

Meanwhile, PMA and Sphingosine-1-phosphate specifically target protein kinase C and sphingosine-1-phosphate receptors, respectively, indicating a mechanism where secondary messengers could influence the signaling landscape to favor 2810433K01Rik activation. The biochemical landscape for 2810433K01Rik activation is further refined by modulators like U73122 and SB203580, which respectively inhibit phospholipase C and p38 MAPK. These inhibitions could lead to a redirection of signaling traffic in a manner that promotes the activity of 2810433K01Rik by disabling competing signal transduction routes or by lifting inhibitory feedback loops. LY294002's PI3K inhibition might also provoke a compensatory upregulation of alternative pathways that converge on the activation of 2810433K01Rik. Collectively, these chemical agents constitute a network of indirect activators that enhance 2810433K01Rik's activity without necessitating direct interaction with the protein. Each activator's mechanism highlights the intricate interplay between different signaling molecules and pathways that coalesce to regulate the function of 2810433K01Rik, revealing the complexity and precision of cellular signaling modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a PKC activator that mimics diacylglycerol. PKC activation can lead to phosphorylation of proteins that are part of the signaling pathways in which 2810433K01Rik operates, potentially enhancing its activity through downstream effects.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which may activate calcium-dependent kinases that phosphorylate 2810433K01Rik or proteins in its pathway, leading to its activation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, SB203580 might allow for the activation of alternative pathways or relieve negative feedback loops that could enhance the activity of 2810433K01Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. Inhibition of PI3K can alter AKT signaling and other downstream pathways that may lead to the activation of 2810433K01Rik through compensatory mechanisms.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG inhibits several protein kinases, potentially affecting signal transduction pathways and possibly leading to the enhancement of 2810433K01Rik activity if it is regulated by any of these kinases.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor that may enhance 2810433K01Rik activity by preventing phosphorylation of proteins that would otherwise suppress 2810433K01Rik's function or by shifting the equilibrium of signaling pathways.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which could enhance the activity of 2810433K01Rik by modulating signaling pathways that involve lipid signaling components that interact with 2810433K01Rik.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to a rise in cytosolic calcium levels, which might enhance 2810433K01Rik activity if it is sensitive to calcium-dependent signaling.